Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Molecular Horticulture|July 7, 2026
A miR858 variant negatively regulates resistance to tea leaf spot through targeting the CsMYB1-CsPME41 moduleDongqin Zhang, Bin Wang, Zeqi Qi, et al.Genes|July 27, 2024
Advances in CircRNAs in the Past Decade: Review of CircRNAs Biogenesis, Regulatory Mechanisms, and Functions in PlantsDongqin Zhang, Yue Ma, Misbah Naz, et al.Carbohydrate Polymers|November 8, 2023
Supramolecular chitin-based hydrogels with self-adapting and fast-degradation properties for enhancing wound healingWenwen Shi, Dongqin Zhang, Luyao Han, et al.Biogerontology|February 5, 2026
Muscle-specific transcriptomic and metabolomic signatures reveal heterogeneous aging trajectories and altered intercellular communication in male murine skeletal muscleCaifen Guo, Xinqiang Lan, Chunping Huang, et al.Plos One|August 11, 2023
Response of soil microbial community diversity to continuous cucumber cropping in facilities along the Yellow River irrigation areaShuchao Huang, Jihua Yu, Dong Hou, et al.Journal of Medicinal Chemistry|March 17, 2012
First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic painGabriela Mladenova, Subhash C Annedi, Jailall Ramnauth, et al.International Immunopharmacology|January 16, 2002
Cocaethylene and heart disease during murine AIDSYingying Liu, Sergio Montes, Dongqin Zhang, et al.Langmuir : the ACS Journal of Surfaces and Colloids|March 11, 2025
Antibacterial Chitin-Based Sponges with Enhanced Water Absorbency and Mechanical Properties for Hemostasis and Wound HealingHaojie Qiu, Ximing Deng, Dongqin Zhang, et al.Journal of Medicinal Chemistry|September 20, 2011
Discovery of N-(3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-6-yl) thiophene-2-carboximidamide as a selective inhibitor of human neuronal nitric oxide synthase (nNOS) for the treatment of painSubhash C Annedi, Shawn P Maddaford, Gabriela Mladenova, et al.European Journal of Medicinal Chemistry|July 31, 2012
Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraineSubhash C Annedi, Shawn P Maddaford, Jailall Ramnauth, et al.Pageof 3